Kura Oncology (KURA) Long-Term Debt Issuances (2010 - 2015)
Kura Oncology's (KURA) quarterly Long-Term Debt Issuances came in at -$3.6 million in Q2 2015, down 183.45% on a QoQ basis from $4.3 million in Q1 2015.
Kura Oncology (KURA) Long-Term Debt Issuances (2010 - 2015) Analysis & Trends
Kura Oncology (KURA) has 5 years of Long-Term Debt Issuances data on file, last reported at -$3.6 million in Q2 2015.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$3.6 million in Q2 2015; TTM through Sep 2016 was -$3.6 million, a 232.1% decrease from a year earlier, with the FY2022 full-year figure at $10.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q2 2015 stood at -$3.6 million, down from $4.3 million in the prior quarter.
- Over the last five years, Long-Term Debt Issuances for KURA reached as high as $4.3 million in Q1 2015 and fell as low as -$3.6 million in Q2 2015.
- Historically, Long-Term Debt Issuances has averaged $476666.7 across 4 years, with a median of $62500.0 in 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kura Oncology | 925.97 Mn | 925.97 Mn | 18.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -3.58 Mn |
| Jun 30, 2015 | -3.58 Mn |
| Mar 31, 2015 | 4.29 Mn |
| Mar 31, 2015 | 4.29 Mn |
| Dec 31, 2014 | 2.00 Mn |
| Dec 31, 2014 | 2.00 Mn |
| Sep 30, 2014 | 100,000.00 |
| Sep 30, 2014 | 100,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2010 | 35,000.00 |
| Dec 31, 2010 | 35,000.00 |